AMBS is a bifurcated company - meaning divide into 2 branches:

http://www.amarantus.com/pipeline

1.) Theraputics

MANF
Phenoguard
Eltoprazine

2.) Diagnostics

LymPro
NeuroPro
BC-SeraPro

Dr. Keywood's 'stellar' professional involvement with PD LID is the main reason why she was brought on board for the Theraputics Division which involves Eltoprazine:

"Dr. Keywood brings tremendous clinical drug development experience to Amarantus, particularly in the area of PD LID," said Gerald E. Commissiong, President & CEO of Amarantus. "We believe this experience will be of great value to Amarantus as we prepare to continue the development of Eltoprazine into Phase 2b clinical trials, given her stellar track record in PD LID liaising with Key Opinion leaders and clinical sites and her strong relationships within the community. Dr. Keywood is an excellent addition to our team and will work closely with Dr. David Lowe to execute our clinical strategy."

http://globenewswire.com/news-release/2014/04...VrRmS.dpuf